Local Phone: 0845 260 2602
Ipsen has announced it will present new study data on Dysport (abobotulinumtoxinA) across stroke and other neurological disorders at...
Read Moreargenx has announced that the US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics...
Read MoreThe UK’s medicines regulator has authorised GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled chronic...
Read MoreBial has introduced a new sublingual formulation of apomorphine in the United Kingdom, providing an additional “rescue” treatment option...
Read MoreGenfit has announced encouraging preliminary findings from a phase 1b clinical trial evaluating its investigational therapy, GNS561, in combination...
Read MoreFinnish biotechnology company NADMED has announced the launch of the NADMED Award 2026, positioning it as a catalyst for...
Read More
